Literature DB >> 15719702

The Abbott Architect c8000: analytical performance and productivity characteristics of a new analyzer applied to general chemistry testing.

Daniela Pauli1, Michael Seyfarth, Leif Dibbelt.   

Abstract

Applying basic potentiometric and photometric assays, we evaluated the fully automated random access chemistry analyzer Architect c8000, a new member of the Abbott Architect system family, with respect to both its analytical and operational performance and compared it to an established high-throughput chemistry platform, the Abbott Aeroset. Our results demonstrate that intra- and inter-assay imprecision, inaccuracy, lower limit of detection and linear range of the c8000 generally meet actual requirements of laboratory diagnosis; there were only rare exceptions, e.g. assays for plasma lipase or urine uric acid which apparently need to be improved by additional rinsing of reagent pipettors. Even with plasma exhibiting CK activities as high as 40.000 U/l, sample carryover by the c8000 could not be detected. Comparison of methods run on the c8000 and the Aeroset revealed correlation coefficients of 0.98-1.00; if identical chemistries were applied on both analyzers, slopes of regression lines approached unity. With typical laboratory workloads including 10-20% STAT samples and up to 10% samples with high analyte concentrations demanding dilutional reruns, steady-state throughput numbers of 700 to 800 tests per hour were obtained with the c8000. The system generally responded to STAT orders within 2 minutes yielding analytical STAT order completion times of 5 to 15 minutes depending on the type and number of assays requested per sample. Due to its extended test and sample processing capabilities and highly comfortable software, the c8000 may meet the varying needs of clinical laboratories rather well.

Entities:  

Mesh:

Year:  2005        PMID: 15719702

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  3 in total

1.  Salivary levels of phosphorus and urea as indices of their plasma levels in nephropathic patients.

Authors:  Giancarlo Bilancio; Pierpaolo Cavallo; Cinzia Lombardi; Ermanno Guarino; Vincenzo Cozza; Francesco Giordano; Giuseppe Palladino; Massimo Cirillo
Journal:  J Clin Lab Anal       Date:  2018-03-30       Impact factor: 2.352

2.  Saliva for assessing creatinine, uric acid, and potassium in nephropathic patients.

Authors:  Giancarlo Bilancio; Pierpaolo Cavallo; Cinzia Lombardi; Ermanno Guarino; Vincenzo Cozza; Francesco Giordano; Giuseppe Palladino; Massimo Cirillo
Journal:  BMC Nephrol       Date:  2019-07-04       Impact factor: 2.388

3.  Sodium Intake and Proteinuria/Albuminuria in the Population-Observational, Cross-Sectional Study.

Authors:  Massimo Cirillo; Pierpaolo Cavallo; Enrico Zulli; Rachele Villa; Rosangela Veneziano; Simona Costanzo; Sara Magnacca; Augusto Di Castelnuovo; Licia Iacoviello
Journal:  Nutrients       Date:  2021-04-11       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.